Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
Clinical trial NCT06282445 · RECRUITING
Trial details
- NCT number
- NCT06282445
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-03-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.